Bill Maher, Director at abrdn Life Sciences Investors (HQL), bought 650 shares at $15.37 ($10K) on 2024-08-23, disclosed to the SEC on 2024-08-27.
Open-market purchase of $10k HQL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AEF | BUY | 2024-08-16 | $5K | — | Filing → |
| JEQ | BUY | 2024-08-16 | $6K | — | Filing → |
| THW | BUY | 2024-08-16 | $13K | — | Filing → |